3-iodobenzylguanidine has been researched along with EHS Tumor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hummel, M; Kelleher, DK; Thews, O; Vaupel, P | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and EHS Tumor
| Article | Year |
|---|---|
Can tumor oxygenation be improved by reducing cellular oxygen consumption.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Male; Oxygen; Oxygen Consumption; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Sarcoma, Experimental | 1999 |